Search research articles
Contact Us
Filters
Showing results (111-120 of 130) with videos related to
Page
of 13
Sort By:
Aging Clinical and Experimental Research
|
March 7, 2025
COVID-19 booster doses reduce sex disparities in antibody responses among nursing home residents
Oladayo A Oyebanji, Anna Yin, Nicholas Sundheimer, et al.
Biochemistry
|
April 28, 2015
Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases
Maria F Mojica, S Graciela Mahler, Christopher R Bethel, et al.
The Journal of Infectious Diseases
|
May 18, 2019
Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa
Krisztina M Papp-Wallace, Elise T Zeiser, Scott A Becka, et al.
Journal of the American Heart Association
|
March 10, 2026
Specific Deficiency of Naïve CD4+ T Lymphocytes Characterizes Heart Failure and Heightens Mortality Risk in the HRS
David A Zidar, Michael L Freeman, Brigid M Wilson, et al.
Iscience
|
May 7, 2026
Single-cell transcriptomics reveal altered B cell responses and T cell senescence in geriatric non-responders to COVID-19 mRNA vaccination
Jeeda Ismail, Banumathi Tamilselvan, Michael Rubsamen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2018
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV
Scott R Evans, Thuy Tien T Tran, Andrea M Hujer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 7, 2023
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers
Clare Nugent, Yasin Abul, Elizabeth White, et al.
Vaccine
|
April 28, 2023
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers
Clare Nugent, Yasin Abul, Elizabeth M White, et al.
Vaccine
|
January 25, 2026
Antibody responses to SARS-CoV-2 vaccine in nursing home residents support a Bi-annual update schedule
Alexandra N Paxitzis, Oladayo A Oyebanji, Olajide J Olagunju, et al.
MMWR. Morbidity and Mortality Weekly Report
|
January 26, 2023
SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022
David H Canaday, Oladayo A Oyebanji, Elizabeth M White, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 130) with videos related to
Sort By:
Page
of 13
Aging Clinical and Experimental Research
|
March 7, 2025
COVID-19 booster doses reduce sex disparities in antibody responses among nursing home residents
Oladayo A Oyebanji, Anna Yin, Nicholas Sundheimer, et al.
Biochemistry
|
April 28, 2015
Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases
Maria F Mojica, S Graciela Mahler, Christopher R Bethel, et al.
The Journal of Infectious Diseases
|
May 18, 2019
Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa
Krisztina M Papp-Wallace, Elise T Zeiser, Scott A Becka, et al.
Journal of the American Heart Association
|
March 10, 2026
Specific Deficiency of Naïve CD4+ T Lymphocytes Characterizes Heart Failure and Heightens Mortality Risk in the HRS
David A Zidar, Michael L Freeman, Brigid M Wilson, et al.
Iscience
|
May 7, 2026
Single-cell transcriptomics reveal altered B cell responses and T cell senescence in geriatric non-responders to COVID-19 mRNA vaccination
Jeeda Ismail, Banumathi Tamilselvan, Michael Rubsamen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2018
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV
Scott R Evans, Thuy Tien T Tran, Andrea M Hujer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 7, 2023
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers
Clare Nugent, Yasin Abul, Elizabeth White, et al.
Vaccine
|
April 28, 2023
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers
Clare Nugent, Yasin Abul, Elizabeth M White, et al.
Vaccine
|
January 25, 2026
Antibody responses to SARS-CoV-2 vaccine in nursing home residents support a Bi-annual update schedule
Alexandra N Paxitzis, Oladayo A Oyebanji, Olajide J Olagunju, et al.
MMWR. Morbidity and Mortality Weekly Report
|
January 26, 2023
SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022
David H Canaday, Oladayo A Oyebanji, Elizabeth M White, et al.
Page
of 13